Copyright
©The Author(s) 2022.
World J Gastroenterol. Aug 14, 2022; 28(30): 4089-4101
Published online Aug 14, 2022. doi: 10.3748/wjg.v28.i30.4089
Published online Aug 14, 2022. doi: 10.3748/wjg.v28.i30.4089
Figure 2 Sequence homology of target antigens of validated antibodies and overlap of antibodies among Crohn’s disease and ulcerative colitis.
A: Heatmap showing sequence homology among target antigens for antibodies with validated performance of ≥ 14% sensitivity at 96% specificity comparing Crohn’s disease (CD) patients with healthy controls; B: CD_IgG, ulcerative colitis (UC)_IgG, CD_IgA and UC_IgG represent the overlap of anti-microbial antibodies of IgG and IgA isotypes in CD and UC patients with ≥ 14% sensitivity at 96% specificity against healthy controls in the discovery set. CD: Crohn’s disease; UC: Ulcerative colitis.
- Citation: Shome M, Song L, Williams S, Chung Y, Murugan V, Park JG, Faubion W, Pasha SF, Leighton JA, LaBaer J, Qiu J. Serological profiling of Crohn’s disease and ulcerative colitis patients reveals anti-microbial antibody signatures. World J Gastroenterol 2022; 28(30): 4089-4101
- URL: https://www.wjgnet.com/1007-9327/full/v28/i30/4089.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i30.4089